Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Vascular Access Device Market, by Application
1.4.2 North America Vascular Access Device Market, by End User
1.4.3 North America Vascular Access Device Market, by Type
1.4.4 North America Vascular Access Device Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis – Global
4.1 Market Share Analysis, 2022
4.2 Porter’s Five Force Analysis
Chapter 5. North America Vascular Access Device Market by Application
5.1 North America Drug Administration Market by Country
5.2 North America Fluid & Nutrition Administration Market by Country
5.3 North America Blood Transfusion Market by Country
5.4 North America Diagnostics & Testing Market by Country
Chapter 6. North America Vascular Access Device Market by End User
6.1 North America Hospital Market by Country
6.2 North America Clinics & Ambulatory Care Centers Market by Country
6.3 North America Others Market by Country
Chapter 7. North America Vascular Access Device Market by Type
7.1 North America Central Vascular Access Device Market by Country
7.2 North America Vascular Access Device Market by Central Vascular Access Device Type
7.2.1 North America Tunneled Catheters Market by Country
7.2.2 North America Peripherally Inserted Central Catheters Market by Country
7.2.3 North America Non-tunneled Catheters Market by Country
7.2.4 North America Implanted Ports Market by Country
7.3 North America Peripheral Vascular Access Device Market by Country
7.4 North America Vascular Access Device Market by Peripheral Vascular Access Device Type
7.4.1 North America Peripheral Midlines Devices Market by Country
7.4.2 North America Peripheral Short Devices Market by Country
7.4.3 North America Butterfly/winged Steel Needles Market by Country
7.5 North America Accessories Market by Country
Chapter 8. North America Vascular Access Device Market by Country
8.1 US Vascular Access Device Market
8.1.1 US Vascular Access Device Market by Application
8.1.2 US Vascular Access Device Market by End User
8.1.3 US Vascular Access Device Market by Type
8.1.3.1 US Vascular Access Device Market by Central Vascular Access Device Type
8.1.3.2 US Vascular Access Device Market by Peripheral Vascular Access Device Type
8.2 Canada Vascular Access Device Market
8.2.1 Canada Vascular Access Device Market by Application
8.2.2 Canada Vascular Access Device Market by End User
8.2.3 Canada Vascular Access Device Market by Type
8.2.3.1 Canada Vascular Access Device Market by Central Vascular Access Device Type
8.2.3.2 Canada Vascular Access Device Market by Peripheral Vascular Access Device Type
8.3 Mexico Vascular Access Device Market
8.3.1 Mexico Vascular Access Device Market by Application
8.3.2 Mexico Vascular Access Device Market by End User
8.3.3 Mexico Vascular Access Device Market by Type
8.3.3.1 Mexico Vascular Access Device Market by Central Vascular Access Device Type
8.3.3.2 Mexico Vascular Access Device Market by Peripheral Vascular Access Device Type
8.4 Rest of North America Vascular Access Device Market
8.4.1 Rest of North America Vascular Access Device Market by Application
8.4.2 Rest of North America Vascular Access Device Market by End User
8.4.3 Rest of North America Vascular Access Device Market by Type
8.4.3.1 Rest of North America Vascular Access Device Market by Central Vascular Access Device Type
8.4.3.2 Rest of North America Vascular Access Device Market by Peripheral Vascular Access Device Type
Chapter 9. Company Profiles
9.1 ICU Medical, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 SWOT Analysis
9.2 Teleflex, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.2.6 SWOT Analysis
9.3 B. Braun Melsungen AG
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Product Launches and Product Expansions:
9.3.6 SWOT Analysis
9.4 Medtronic PLC
9.4.1 Company overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 SWOT Analysis
9.5 Terumo Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Product Launches and Product Expansions:
9.5.6 SWOT Analysis
9.6 Becton, Dickinson and Company
9.6.1 Company Overview
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Acquisition and Mergers:
9.6.6 SWOT Analysis
9.7 AngioDynamics, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.6 SWOT Analysis
9.8 Edwards Lifesciences Corporation
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 SWOT Analysis
9.9 Nipro Corporation
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 SWOT Analysis
9.10. Romsons
9.10.1 Company Overview
9.10.2 SWOT Analysis
Unique Offerings 